Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

chemische fabrik kreussler & co gesellschaft mit beschränkter haftung (3040135) - troxerutin - filmtablette - teil 1 - filmtablette; troxerutin (02052) 300 milligramm

Unjoni Ewropea - Ġermaniż - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ursapharm arzneimittel gmbh - troxerutin - hartkapsel - troxerutin 300.mg

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ursapharm arzneimittel gmbh - troxerutin - hartkapsel - troxerutin 300.mg

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ursapharm arzneimittel gmbh (3091196) - troxerutin - kapsel - troxerutin (2052) 300 milligramm

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

omega pharma deutschland gmbh (3074861) - troxerutin; buchweizenblätter - filmtablette - teil 1 - filmtablette; troxerutin (02052) 30 milligramm; buchweizenblätter (17385) 50 milligramm

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - pirtobrutinibum - filmtabletten - pirtobrutinibum 50 mg, hypromellosi acetas succinas, cellulosum microcristallinum, lactosum monohydricum 38.26 mg, carmellosum natricum conexum corresp. natrium 0.7 mg, silica colloidalis hydrica, magnesii stearas, pellicule: hypromellosum, e 171, triacetinum, e 132, pro compresso obducto. - oncologica - synthetika

Svizzera - Ġermaniż - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - pirtobrutinibum - filmtabletten - pirtobrutinibum 100 mg, hypromellosi acetas succinas, cellulosum microcristallinum, lactosum monohydricum 76.53 mg, carmellosum natricum conexum corresp. natrium 1.4 mg, silica colloidalis hydrica, magnesii stearas, pellicule: hypromellosum, e 171, triacetinum, e 132, pro compresso obducto. - oncologica - synthetika

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

truw arzneimittel gmbh - troxerutin - filmtablette - troxerutin 250.mg

Ġermanja - Ġermaniż - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

schaper & brümmer gmbh & co.kg - troxerutin, cumarin - dragees - troxerutin 90.mg; cumarin 15.mg